Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease

Abstract

Oral ferrous fumarate, but not intravenous iron sucrose, increased clinical disease activity in IBD patients. Intravenous iron sucrose increased intravascular oxidative stress.